SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001654954-19-000534
Filing Date
2019-01-16
Accepted
2019-01-16 17:29:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 caribou13ga_dec312018.htm SC 13G/A 84349
  Complete submission text file 0001654954-19-000534.txt   85846
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filed by) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89486 | Film No.: 19529709
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences